10 Biggest Price Target Changes For Friday
Keybanc raised the price target on Twitter, Inc. (NYSE: TWTR) from $77 to $81. Twitter shares rose 6.4% to $74.00 in pre-market trading.
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
32 Stocks Moving in Friday’s Pre-Market Session
Gainers
Socket Mobile Inc (NASDAQ: SCKT) shares rose 100.2% to $11.61 in pre-market trading after the company reported better-than-expected Q2 results.
Cantor Fitzgerald Downgrades Adverum Biotechnologies to Neutral, Lowers Price Target to $3
Cantor Fitzgerald analyst Alethia Young downgrades Adverum Biotechnologies (NASDAQ:ADVM) from Overweight to Neutral and lowers the price target from $23 to $3.
Adverum Stock Falls As It Stops Testing Ocular Gene Therapy Candidate In Diabetic Macular Edema Patients
Adverum Biotechnologies Inc (NASDAQ:ADVM) has decided to drop the development of ADVM-022 intravitreal (IVT) injection gene therapy in diabetic macular edema…
SVB Leerink Maintains Market Perform on Adverum Biotechnologies, Lowers Price Target to $2
SVB Leerink analyst Mani Foroohar maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Market Perform and lowers the price target from $5 to $2.
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 19)
Understanding Adverum Biotechnologies’s Unusual Options Activity
Shares of Adverum Biotechnologies (NASDAQ:ADVM) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $3.
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 15)
Stocks That Hit 52-Week Lows On Thursday
During the morning session on Thursday, 152 stocks hit new 52-week lows.